| Authors: |
Watts GF; School of Medicine, University of Western Australia and Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. gerald.watts@uwa.edu.au., Scott R; New Zealand Clinical Research, Christchurch, New Zealand., Sullivan D; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Baker J; Middlemore Hospital, Auckland, New Zealand., Clifton P; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Hamilton J; Arrowhead Pharmaceuticals Inc., Pasadena, CA, USA., Given B; Arrowhead Pharmaceuticals Inc., Pasadena, CA, USA., Melquist S; Arrowhead Pharmaceuticals Inc., Pasadena, CA, USA., Zhou R; Arrowhead Pharmaceuticals Inc., Pasadena, CA, USA., Gaudet D; Dept of Medicine, Université de Montréal, and ECOGENE 21 QC, Montréal, Quebec, Canada., Goldberg IJ; NYU School of Medicine, NYU Langone Health, New York City, NY, USA., Knowles JW; Stanford Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA., Leeper NJ; Stanford Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA., Hegele RA; Robarts Research Institute, London, Ontario, Canada., Ballantyne CM; Baylor College of Medicine and the Texas Heart Institute, Houston, TX, USA. |
